2024-519820-26-00
CTIS ↗
Placebo for ML-007C-MA bilayer tablet
Hallucinations and Delusions Associated with Alzheimer’s Disease Psychosis
pharma · Schizophrenia · Hallucinations and Delusions Associated with Alzheimer’s Disease Psychosis · MPLT
MapLight Therapeutics
MapLight Therapeutics trial registry — 7 ClinicalTrials.gov studies with program phase, status, and indication context.
atlanta, USA HQ
2017 Founded
7 Employees
Public company Type
MPLT · NYSE Ticker
Company details
- Status
- Public
- HQ
- atlanta, USA
- Founded
- 2017
- Employees
- 7
- Programs
- 5
- Drugs
- 5
- Patents
- 0
MapLight Therapeutics clinical trials
Registry index of 7 ClinicalTrials.gov studies linked to MapLight Therapeutics programs — each row shows trial ID, program name, phase, status, and indication.
MapLight Therapeutics trial registry — 7 ClinicalTrials.gov studies with program phase, status, and indication context.
Recent trial activity
Latest clinical program signals indexed for MapLight Therapeutics.